Results 241 to 243 of about 65,592 (243)

Pembrolizumab versus Ipilimumab in Advanced Melanoma

New England Journal of Medicine, 2015
Caroline Robert, Georgina V Long, Ana Arance   +2 more
exaly  

Nivolumab plus ipilimumab versus lenvatinib or sorafenib as first-line treatment for unresectable hepatocellular carcinoma (CheckMate 9DW): an open-label, randomised, phase 3 trial

Lancet, The
Leonardo G Da Fonseca, Hong-Jae Chon, Matsatoshi Kudo   +2 more
exaly  

Ipilimumab

Reactions Weekly, 2020
openaire   +1 more source